+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

DEMTECH

Alzheimer Nederland

The DEMTECH program aims to promote the development of innovative and user-friendly technologies so that people with dementia can live independently at home for longer. DEMTECH does this by offering knowledge institutions, companies and healthcare organizations co-financing to develop these technologies.

In 2040, there are expected to be 500,000 people with dementia. Almost 80% of these people live at home. At the same time, the staff shortage in healthcare is growing and the availability of informal care is decreasing. This calls for a fundamental change in the support of people with dementia.

Our mission

DEMTECH's mission is to promote self-reliance and autonomy in the daily lives of people with dementia in the home situation, to prevent crisis situations and to relieve the pressure on informal caregivers and professional care. We do this by developing innovative technologies for a fundamental change in dementia care.

What we do

On April 1, 2025, DEMTECH opened a call for proposals for consortia of knowledge institutes, healthcare organizations and companies to submit project proposals. The deadline for submitting applications is July 1, 2025 at 5:00 PM.

For selected projects we organize co-creation sessions and user research to improve the content of the projects. Before and after this an independent assessment committee will assess the projects.

AI Based Application Success Predictor

🧬 1. Alignment with Research Agenda & Impact

Projects must align with Alzheimer Nederland’s strategic research agenda, which emphasizes improving quality of life, care innovations, and implementation/outcome-focused research—rather than prevention or cures .

Emphasis is placed on applied clinical or psychosocial research targeting measurable improvements in dementia care and everyday life .

🕒 2. Career Stage Appropriate & Mentored

Impuls Grant (up to €150K) supports promising early-career researchers, including late PhD candidates and postdocs, to develop their own research line .

Fellowships (short & long) are available for researchers within 4 years post-PhD to foster international exchange and specialization .

💰 3. Financially Focused, Flexible Schemes

Small Grants (scholarships for internships, conference attendance, thesis printing) are available year-round with quick (~4–6 weeks) evaluation timelines .

Impuls Grant opens three rounds per year—typical award up to €150K .

🔄 4. Strategic Use of the Impulssubsidie

Projects recommended in high-rated but unfunded NWO/ZonMw proposals can be considered under the Impulssubsidie—up to €300K if they align with Alzheimer Nederland priorities .

🏛️ 5. Strong Institutional & Supervisor Support

Small grants require a confirmation letter from the internship supervisor abroad .

Fellowships and Impuls Grants expect institutional backing and infrastructure for effective implementation .

🔧 6. Clear Reporting & Acknowledgment

Successful applicants must:

Acknowledge Alzheimer Nederland in publications and presentations

Submit a brief scientific report post-internship or mid-project

Use Alzheimer Nederland’s logo in outputs

📋 Summary Table

Funding Type	Success Factors
Small Grants (internships, conference, thesis)	Fit early-career; strong mentor support; fit within financial caps; rapid, complete submissions
Impuls Grant	Aligned with research agenda; early-career independence; high critique NWO/ZonMw proposal leverage; institutional readiness
Fellowships (short/long)	Within 4 years post-PhD; international collaboration; specialization relevance; formal support letter
Impulssubsidie	Previously peer-reviewed (NWO/ZonMw) and top-rated; submitted within 6 months of rejection; research agenda alignment

✅ Tips to Boost Funding Odds

Choose the right scheme for your stage—small grants for internships/conferences, Impuls for launch projects, fellowships for training abroad.

Match with Alzheimer Nederland’s research agenda—focus on improving patient care, everyday living, or psychosocial outcomes.

Secure strong mentorship and institutional backing, particularly letters from abroad for internships/fellowships.

Leverage high-scoring but unfunded NWO/ZonMw proposals through the Impulssubsidie.

Prepare for acknowledgment and reporting compliance—mention updates on deliverables and logo usage.

Submit well before deadlines—year-round small grants need 4–6 weeks for review; Impuls grants have specific rounds.

Specialties

Technology Development

Eligibility Requirements

Applications are open to collaboration teams of at least three independent and complementary Dutch Parties.

Eligible Countries:

Netherlands

Sponsor Details

Sponsor Institute/Organizations: Alzheimer Nederland

Sponsor Type: Corporate/Non-Profit

Address: PO Box 2077, 3800 CB Amersfoort

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity